Ofatumumab, a fully human anti-CD20 monoclonal antibody, in the treatment of severe refractory Anti-N-methyl-D-aspartate receptor encephalitis: Two case reports

Ofatumumab, a fully human anti-CD20 monoclonal antibody, in the treatment of severe refractory Anti-N-methyl-D-aspartate receptor encephalitis: Two case reports

Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is a type of autoimmune encephalitis (AE) characterized by antibodies against NMDA receptor. As the most common AE, anti-NMDAR encephalitis affects 54% ~ 80% of patients with AE. It is associated with a high percentage of severe illness. It typi...

Full description

Bibliographic Details
Main Authors: Hongfei Xue, Yushu Jiang, Lingzhi Qin, Xiaojuan Wang, Milan Zhang, Shuhua Dai, Yongshi Teng, Jiajia Xu, Wei Li
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Annals of Indian Academy of Neurology
Subjects:
anti-n-methyl-d-aspartate
case report
encephalitis
nmda
ofatumumab
Online Access:http://www.annalsofian.org/article.asp?issn=0972-2327;year=2023;volume=26;issue=5;spage=774;epage=777;aulast=Xue

Internet

http://www.annalsofian.org/article.asp?issn=0972-2327;year=2023;volume=26;issue=5;spage=774;epage=777;aulast=Xue

Similar Items